Genistein, a Tyrosine Kinase Inhibitor, Reduces EGF-Induced EGF Receptor Internalization and Degradation in Human Hepatoma HepG2 Cells

By Yang E.B.   Wang D.F.   Mack P.   Cheng L.Y.  

Biochemical and Biophysical Research Communications, Vol. 224, Iss. 2, 1996-07 ,pp. : 309-317

Elsevier

Access to resources Recommend Favorite

Metabolic disposition of gefitinib, an epidermal growth factor receptor tyrosine kinase inhibitor, in rat, dog and man

By McKillop D.   Hutchison M.   Partridge E. A.   Bushby N.   Cooper C. M. F.   Clarkson-Jones J. A.   Herron W.   Swaisland H. C.  

Xenobiotica, Vol. 34, Iss. 10, 2004-10 ,pp. : 917-934

Informa Healthcare

Access to resources Recommend Favorite

Pharmacokinetics of gefitinib, an epidermal growth factor receptor tyrosine kinase inhibitor, in rat and dog

By McKillop D.   Partridge E. A.   Hutchison M.   Rhead S. A.   Parry A. C.   Bardsley J.   Woodman H. M.   Swaisland H. C.  

Xenobiotica, Vol. 34, Iss. 10, 2004-10 ,pp. : 901-915

Informa Healthcare

Access to resources Recommend Favorite

The Trk tyrosine kinase inhibitor K252a regulates growth of lung adenocarcinomas

By Perez-Pinera P.   Hernandez T.   García-Suárez O.   Carlos F.   Germana A.   Valle M.   Astudillo A.   Vega J.  

Molecular and Cellular Biochemistry, Vol. 295, Iss. 1-2, 2007-01 ,pp. : 19-26

Springer Publishing Company

Access to resources Recommend Favorite

Differential Phosphoprofiles of EGF and EGFR Kinase Inhibitor-Treated Human Tumor Cells and Mouse Xenografts

By Stover David R.   Caldwell Jennifer   Marto Jarrod   Root Karen   Mestan Juergan   Stumm Michael   Ornatsky Olga   Orsi Chris   Radosevic Nina   Liao Linda   Fabbro Doriano   Moran MichaelF.  

Clinical Proteomics, Vol. 1, Iss. 1, 2004-03 ,pp. : 69-80

Humana Press, Inc

Access to resources Recommend Favorite